CTSO and breast cancer: Our previous GWAS study identified SNPs on chromosome 4, near the CTSO gene that were associated with increased risk for the development of breast cancer during five years of breast cancer prevention therapy with tamoxifen or raloxifene in the NSABP P-1 and P-2 breast cancer prevention trials [20].